Basudeb Das
PhD Scholar in the Department of Life Science · National Institute of Technology Rourkela
https://researchid.co/bd_87824392
@nitrkl.ac.in
12Scopus Publications
344Google Scholar Citations
11Google Scholar h-index
12Google Scholar i10-index
Research Interests
NcRNAs, Cancer, Molecular Physiology
Biography
Development of PIWI-interacting RNA (piRNA) - based diagnostic markers and therapies to treat cancer: Deciphering mechanisms of dysregulation of piRNAs and their interplay with epigenetic regulators. Use piRNAs to restrict malignancy, increase chemotherapeutic sensitivity and targeted killing of malignant cancers.
Education
Master of Science (M. Sc.) in Human Physiology
Recent Scopus Publications
- Corrigendum to “Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways” Pathol. - Res. Pract. 237 (2022) 154029 (Pathology - Research and Practice (2022) 237, (S0344033822002734), (10.1016/j.prp.2022.154029))
- Kaempferol attenuates viability of ex-vivo cultured post-NACT breast tumor explants through downregulation of p53 induced stemness, inflammation and apoptosis evasion pathways
- HIWI2 induces G2/M cell cycle arrest and apoptosis in human fibrosarcoma via the ROS/DNA damage/p53 axis
- Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma
- miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux
Links
- ORCID https://orcid.org/0000-0001-8782-4392
- Google Scholar https://scholar.google.com/citations?user=x6bCuSAAAAAJ
- Scopus https://www.scopus.com/authid/detail.uri?authorId=57209125917